A detailed history of Interchange Capital Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 14,880 shares of ABT stock, worth $1.75 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
14,880
Previous 15,403 3.4%
Holding current value
$1.75 Million
Previous $1.6 Million 6.0%
% of portfolio
0.61%
Previous 0.59%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $52,336 - $61,781
-523 Reduced 3.4%
14,880 $1.7 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $1.36 Million - $1.52 Million
13,508 Added 712.82%
15,403 $1.6 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $207,540 - $229,219
1,895 New
1,895 $215,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $1,815 - $2,177
19 Added 0.82%
2,339 $226,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $1.17 Million - $1.3 Million
-11,579 Reduced 83.31%
2,320 $252,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $1.35 Million - $1.58 Million
13,899 New
13,899 $1.41 Million
Q3 2022

Nov 07, 2022

BUY
$96.76 - $112.03 $257,671 - $298,335
2,663 New
2,663 $257,000
Q4 2021

Feb 04, 2022

SELL
$115.53 - $141.46 $1.63 Million - $1.99 Million
-14,085 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $17,965 - $19,875
-154 Reduced 1.08%
14,085 $1.66 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $12,800 - $15,068
-121 Reduced 0.84%
14,239 $1.65 Million
Q1 2021

May 05, 2021

BUY
$108.84 - $128.23 $3,374 - $3,975
31 Added 0.22%
14,360 $1.72 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $1.5 Million - $1.64 Million
14,329 New
14,329 $1.57 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.